← Open Payments lookup

CHIMA ASIKAIWE: Open Payments

NPI 1992003669 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$508 in 20 payments from 11 companies in 2025. Trend: 2023 $621 · 2024 $590 · 2025 $508

Food & beverage: $508
CompanyPaymentsAmount
Brainsway USA INC1$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Corium, LLC3$65
Supernus Pharmaceuticals, Inc.3$56
Janssen Pharmaceuticals, Inc3$53
Vanda Pharmaceuticals Inc.2$44
Axsome Therapeutics, Inc.1$24
Teva Pharmaceuticals USA, Inc.1$21
Tris Pharma Inc1$21
E.R. Squibb & Sons, L.L.C.1$18

Products named: Deep TMS System, CAPLYTA, Azstarys, Qelbree, SPRAVATO, FANAPT, Auvelity, UZEDY.

Industry payments across TX — which companies pay providers there.